Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-07-07 18:30:11
Reporting Period:
Filing Date:
Accepted Time:
2016-07-07 18:30:11
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1226616 Medicinova Inc MNOV Pharmaceutical Preparations (2834) 330927979
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1589471 Geoffrey Obrien C/o Medicinova, Inc.
4275 Executive Square, Suite 650
La Jolla CA 92037
Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-05 3,300 $4.80 8,300 No 4 M Direct
Common Stock Disposition 2016-07-05 3,300 $8.00 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2016-07-05 3,300 $0.00 3,300 $4.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,700 2019-07-06 No 4 M Direct
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. The option vested over a period of 4 years in equal monthly installments from the 7/7/2009 date of grant and is now fully vested.